Screening of BRCA1 and BRCA2 genes and their therapeutic implications in triple-negative breast cancer: a systematic review of the literature
Revista Brasileira de Ciências Biomédicas · 20.11.2026 · 7 (1)
DOI: 10.46675/rbcbm.v7i1.129 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Revista Brasileira de Ciências Biomédicas, online erschienen am 20.11.2026. Verfasst von Julia Barbosa Gomes und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objective: Breast cancer represents one of the most prevalent and deadly neoplasms among women, requiring strategic public health interventions to mitigate its social and clinical impacts. This study aims to analyze the biological and epidemiological aspects of breast cancer in Brazil, highlighting the cellular mechanisms involved in tumor progression and the relevance of early screening.
Methods
This is a narrative literature review focusing on cell cycle regulation, alterations in the synthesis phase (S phase), and regional disparities in access to diagnosis in the Brazilian context. Conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, the searches for this review were performed in the PubMed database, resulting in the selection of 17 articles for analysis Results: The literature indicates that tumor progression is closely associated with failures in cell replication checkpoints, favoring the disordered proliferation of atypical cells. From an epidemiological perspective, significant regional inequalities in disease incidence and mortality are observed, influenced by socioeconomic factors and barriers to healthcare access. However, the implementation of systematic screening programs demonstrates high efficacy in detecting subclinical lesions, significantly increasing cure rates and enabling less invasive therapeutic approaches.
Conclusion
An integrated understanding of cell cycle molecular mechanisms combined with assertive regional screening strategies is essential to reduce mortality, optimize public health resources, and improve patient prognosis and quality of life.
Zitieren
APA
Gomes, J. B., & Souto, R. (2026). Screening of BRCA1 and BRCA2 genes and their therapeutic implications in triple-negative breast cancer: a systematic review of the literature. Revista Brasileira de Ciências Biomédicas, 7(1). https://doi.org/10.46675/rbcbm.v7i1.129
Vancouver
Gomes JB, Souto R. Screening of BRCA1 and BRCA2 genes and their therapeutic implications in triple-negative breast cancer: a systematic review of the literature. Revista Brasileira de Ciências Biomédicas. 2026;7(1). doi:10.46675/rbcbm.v7i1.129
BibTeX
@article{Gomes2026,
author = {Gomes, Julia Barbosa and Souto, Rafael},
title = {Screening of BRCA1 and BRCA2 genes and their therapeutic implications in triple-negative breast cancer: a systematic review of the literature},
journal = {Revista Brasileira de Ciências Biomédicas},
year = {2026},
volume = {7},
number = {1},
doi = {10.46675/rbcbm.v7i1.129}
}
EUVIMED